Statements Of Consolidated Cash Flows | |
Cash and Cash Equivalents, Beginning of Period | 432.76M |
Operating Activities | |
Net income | |
Adjustments to reconcile net income to net cash provided by operating activities: | |
Depreciation and amortization, net of accretion | |
Non-cash compensation and employee benefits | |
Increase in deferred income taxes | |
Provision for uncollectible accounts | -33K |
Loss from impairment of intangible assets | |
Loss (Gain) from sales of property and equipment, net | -1.35M |
Changes in assets and liabilities: | |
Receivables | |
Prepaid expenses | -2.38M |
Accounts payable | 34.71M |
Accrued variable compensation | |
Accrued liabilities, excluding accrued variable compensation and employee benefits | |
Self-insurance accruals | |
Accrued income taxes | 2.64M |
Employee benefits | -26.48M |
Deferred charges and credits | |
Other | |
Net Cash Provided by Operating Activities | |
Investing Activities | |
Capital expenditures | |
Software expenditures | |
Proceeds from sales of property and equipment | |
Purchases of marketable securities | |
Proceeds from sales of marketable securities | |
Net Cash Used in Investing Activities | -112.13M |
Financing Activities | |
Repayment of long-term debt and capital leases | |
Net proceeds from short-term borrowings | 326K |
Proceeds from issuance of common stock | |
Proceeds from exercise of stock options | 559K |
Excess tax benefit from stock-option exercises | 2.91M |
Payments of common dividends | |
Net Cash Used in Financing Activities | -61.3M |
Increase (Decrease) in Cash and Cash Equivalents | 2.32M |
Cash and Cash Equivalents, End of Period | 435.08M |
Supplemental Disclosures | |
Cash paid (refunded) for income taxes, net | 30.04M |
Cash paid for interest, net of amounts capitalized | 25.98M |
Non-cash Financing Activities | |
Capital lease incurred to acquire revenue equipment | 116K |
Repurchased common stock issued under defined contribution plan |